SABRINA DANIEL: Open Payments
NPI 1609009117 · ATLANTA, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$633 in 36 payments from 9 companies in 2025. Trend: 2023 $167 · 2024 $252 · 2025 $633
Food & beverage: $633
| Company | Payments | Amount |
|---|---|---|
| Collegium Pharmaceutical, Inc. | 19 | $203 |
| Averitas Pharma Inc. | 5 | $136 |
| Boston Scientific Corporation | 4 | $99 |
| VERTEX PHARMACEUTICALS INCORPORATED | 2 | $63 |
| Globus Medical, Inc. | 2 | $43 |
| Pacira Pharmaceuticals Incorporated | 1 | $24 |
| Merz Pharmaceuticals, LLC | 1 | $23 |
| Medtronic, Inc. | 1 | $21 |
| SPR Therapeutics, Inc | 1 | $21 |
Products named: Belbuca, QUTENZA, WaveWriter Alpha Prime 16, JOURNAVX, Senza, General - Pain Management, XTAMPZA, Iovera.
Industry payments across GA — which companies pay providers there.
